Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
about
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In VitroThe application of physiologically-based pharmacokinetic modelling to assess the impact of antiretroviral-mediated drug-drug interactions on piperaquine antimalarial therapy during pregnancy.Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations.
P2860
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@ast
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@en
type
label
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@ast
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@en
prefLabel
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@ast
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@en
P2093
P2860
P1476
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy.
@en
P2093
Angela Colbers
Carlijn Litjens
David Burger
P2860
P2888
P304
P356
10.1007/S40262-015-0325-8
P577
2015-09-14T00:00:00Z